Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Professional phagocytes are a specialized group of immune cells, including neutrophils, macrophages, monocytes, dendritic cells, and mast cells, characterized by their highly efficient ability to engulf and digest pathogens, cellular debris, and foreign particles (StatPearls, 2023). These cells play a critical role in the innate immune system by providing the first line of defense against infection and are essential for initiating adaptive immune responses through antigen presentation (Wikipedia, 2024). In various disease states, professional phagocytes can become dysregulated; for instance, tumor-associated macrophages can promote cancer progression by suppressing immune surveillance, while overactive neutrophils contribute to chronic inflammatory tissue damage (PubMed, 2022). While not a single molecular target, these cells are the focus of numerous therapeutic strategies aimed at modulating their recruitment, polarization, or effector functions to treat cancer, autoimmune disorders, and infectious diseases. Drugs such as colony-stimulating factors or receptor inhibitors are frequently used to manipulate these cell populations for clinical benefit.
Therapeutic modulation involves the stimulation of cell production, inhibition of recruitment, or reprogramming of cellular polarization through cytokine signaling or receptor inhibition.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Professional phagocyte.